4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-047279
Chief Executive Officer sold 1,477 shares at $15.00 ($22,155)
- Chief Executive Officer acquired 1,477 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kauffman Michael · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-08-17 | Exercise or conversion : show line 1 in the form | +1,477 | $0.03 | $49 | 757,966 | I |
| 2020-08-17 | Sale : show line 2 in the form | −1,477 | $15.00 | $22,155 | 756,489 | I |
| Open-market sales · 1,477 sh · avg $15.00 · $22,155 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-08-17 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −1,477 | $0.03 | 2020-10-31 | 1,477 | 6,076 | I |
Loading xslF345X03/doc4.xml…